Susan Immanuel

Abstract B129: Repurposed T-Box-Targeting Drug in Liposomal Formulation Shows Synergistic Efficacy Against PDAC

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, largely due to late diagnosis, limited therapeutic response, and its dense desmoplastic stroma, which limits drug penetration. To address the need for more effective treatments, we investigated a repurposed small-molecule inhibitor targ...